HB RKN Container Receives FAA Design Approval

On March 19, HB TempCon Aviation, a subsidiary of Haier Biomedical, successfully passed the airworthiness review by the United States Federal Aviation Administration (FAA) for its independently developed Active Temperature Controlled RKN Container, becoming the first and only company in the Asia-Pacific region to receive an FAA Design Approval Letter (LODA) for an active temperature controlled container.

HB TempCon Aviation also made global history as the first company worldwide to obtain a TSO-C90e design approval letter. This milestone follows its earlier achievement of securing the world's first CTSO-C90e certificate, signifying that it's products meet globally leading standards in safety, technical performance, and quality.

This approval marks another key milestone following the China Civil Aviation Administration's CTSOA certification for HB TempCon RAP model in January 2024. It also highlights the growing recognition of China's high-end aviation equipment by U.S. regulatory authorities, providing a "China Solution" for global biopharmaceutical and high-end cold chain transportation.

Breaking Barriers in Temperature Controlled Transport Through Cutting-Edge Innovation

The FAA airworthiness certification is one of the most stringent regulatory processes in global aviation safety, involving multiple rounds of technical evaluation. HB TempCon Aviation's successful acquisition of the FAA LODA confirms that its temperature controlled equipment has passed comprehensive assessments in technical standards, system safety, testing, and airworthiness compliance, demonstrating that the product fully meets all applicable airworthiness requirements under the Federal Aviation Regulations (FAR). The certification also carries international recognition through the FAA's bilateral agreements, opening access to equivalent certification pathways and significantly enhancing China's footprint in the global market for aviation temperature controlled equipment.

As a core component in cross-border biopharmaceutical transport, active temperature controlled containers must maintain reliable performance under extreme conditions, including sudden changes in air pressure and the need for highly precise temperature control. HB TempCon Active Temperature–Controlled RKN Container delivers ±1°C temperature accuracy throughout the entire transportation process, powered by three core features: an intelligent temperature control system, a redundant safety architecture, and long-endurance technology.

Equipped with a high-capacity battery for extended operation, multi-layered redundancy, and intelligent safety modules, the product ensures exceptional temperature stability and operational reliability. It has already been successfully deployed in the intercontinental transport of high-value, temperature-sensitive materials such as vaccines, blood products, and biological samples.

Building a Smart Pharmaceutical Air Network Through a Global End-to-End Temperature Controlled Ecosystem

Driven by a user-centric approach and a commitment to continuous technological innovation, HB TempCon Aviation is driving both technical and ecological transformation as it accelerates the global deployment of an end-to-end aviation temperature controlled ecosystem. The company provides a full-lifecycle green solution for aviation cold chain logistics, covering R&D, production, operations, and maintenance, injecting new momentum into the high-quality development of global aviation cold chain logistics.

At present, HB TempCon Aviation has already established a rapidly expanding aviation temperature controlled logistics network across China–Europe, China–U.S., and China–Asia-Pacific routes. It has also successfully completed multiple intercontinental biopharmaceutical transport missions—including Shanghai–Chicago, Frankfurt–Shanghai, and Shanghai–Auckland—earning widespread international recognition for its service quality and technical expertise.

As the global temperature controlled logistics landscape continues to evolve, HB TempCon Aviation is reshaping the industry with a "China Solution," setting new benchmarks for high-end aviation temperature controlled logistics equipment under the banner of "China's Intelligent Manufacturing." Moving forward, the company will deepen its collaboration with both domestic and international airlines, as well as leading freight forwarders, to establish a smart pharmaceutical air corridor. By leveraging green, low-carbon technologies to reduce energy consumption and ensuring data security through independently controlled systems, HB TempCon Aviation will continue to expand its global air network, strengthening the international temperature controlled logistics industry and advancing the global presence of China’s biopharmaceutical sector.